Brilliant announcement from IMU today.
Our market has reacted accordingly. It is worth noting that even with today's 23% jump in the company's share price to 2.1c from 1.7c, IMU still only has a Market Cap of $60 million.
I was particularly impressed with this statement:
"Professor Dr Ursula Wiedermann and Imugene CEO Leslie Chong said in a joint announcement "Development of this new immunotherapy has positioned Imugene to be a new and competitive player in the immuno-oncology revolution in cancer therapy. This expands our pipeline and transforms Imugene into a multi-asset biopharmaceutical company."Once word of today's announcement starts to get out in to the wider market (... and the global biotech investment community) I expect a market cap of $180 million to be more appropriate for IMU as compared to the company's peers at similar stages in the drug development pipeline.
IMHO a share price of 6c for IMU isn't too far off...
Market Cap still only $60m - should be $180m!
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
0.002(4.65%) |
Mkt cap ! $334.7M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.5¢ | 4.3¢ | $732.0K | 16.76M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1799587 | 4.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 1003772 | 13 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |